Capcyte Biothérapeutique

Propulsé - BioTech | Hiver 2025

About the company

Capcyte’s mission is to make cardiovascular implants safer through our unique biomolecular coating. We are able to treat most existing implants to enhance their healing potential, thereby limiting complications for patients.

The founders

Hugo Level
Président & CEO
Mariève Boulanger
Directrice finance et administration
Marc-Antoine Campeau
Directeur Technologie
Corinne A Hoesli
Directrice scientifique
Manufacturing

Intelligence Industrielle

Automne 2017
Construction & Mining

Mechasys

Automne 2018
AgriTech

Nectar

Hiver 2017